BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2015

Position Statistics

Total Positions 92
New Positions 9
Increased Positions 25
Decreased Positions 30
Positions with Activity 55
Sold Out Positions 11
Total Mkt Value (in $ millions) 1,058

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 1.47%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 74.77%
Services
Technology
Transportation
Utilities

55 Activity Positions as of 12/31/2015

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
ACCURAY INC COM -4,020 Sold Out 0
BOVIE MEDICAL CORP COM -1,866 Sold Out 0
CARDIOVASCULAR SYS INC DEL COM -16,776 Sold Out 0
FLEXION THERAPEUTICS INC COM -3,361 Sold Out 0
HEARTWARE INTL INC COM -7,996 Sold Out 0
IRADIMED CORP COM -3,771 Sold Out 0
MASIMO CORP COM -18,282 Sold Out 0
ONCOTHYREON INC COM -770 Sold Out 0
SPECTRUM PHARMACEUTICALS INC COM -17,844 Sold Out 0
TETRAPHASE PHARMACEUTICALS INC COM -896 Sold Out 0
ZOSANO PHARMA CORP COM -809 Sold Out 0
BIODEL INC COM NEW 830 -1,310 (61.21) 2,000,000
RXI PHARMACEUTICALS CORP NEW COM 1,138 -222 (16.32) 512,648
VERACYTE INC COM 1,769 -2,501 (58.57) 304,980
WINDTREE THERAPEUTICS INC COM 2,092 269 14.75 777,813
NEXVET BIOPHARMA PUB LTD CO ORD SHS 2,158 2,158 New 721,595
PROTALIX BIOTHERAPEUTICS INC COM 2,754 2,754 New 3,338,570
ARDELYX INC COM 2,798 -1,602 (36.41) 349,290
GENOCEA BIOSCIENCES INC COM 3,723 -880 (19.12) 846,243
EPIRUS BIOPHARMACEUTICALS INC COM 3,988 1,740 77.42 1,375,000